Sherwood, ARNCT06824194Now EnrollingIRB Ready

Pneumococcal infection Clinical Trial in Sherwood, AR

Access cutting-edge pneumococcal infection treatment through this clinical trial at a research site in Sherwood. Study-provided care at no cost to qualified participants.

Sponsored by Sanofi

Quick Self-Assessment

See if you qualify for this Sherwood location

Preparing your pre-screening questions...

Expert Care in Sherwood

Access pneumococcal infection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pneumococcal infection treatment provided free

Apply for This Sherwood Location

Check if you qualify for this pneumococcal infection clinical trial in Sherwood, AR

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Sherwood

    Convenient for AR residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Sherwood site if eligible
  4. 4Begin participation

About This Pneumococcal infection Study in Sherwood

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneumococcal vaccine) compared to a licensed 20-valent pneumococcal conjugate vaccine in infants aged from approximately 2 months (42 to 89 days). The study duration per participant will be up to approximately 19 months. The study vaccines (either PCV21 or 20vPCV) will be administered at approximately 2, 4, 6 and 12 to 15 months of age. Routine pediatr

Sponsor: Sanofi

Who Can Participate

Inclusion Criteria

Aged 42 to 89 days on the day of inclusion
Participants who are healthy as determined by medical evaluation including medical history and physical examination
Born at full term of pregnancy (≥ 37 weeks) and with a birth weight ≥ 2.5 kg or born after a gestation period above 28 (\> 28 weeks) through 36 weeks with a birth weight ≥ 1.5 kg, and in both cases medically stable as assessed by the investigator

Exclusion Criteria

Participants are excluded from the study if any of the following criteria apply:
Known or suspected congenital or acquired immunodeficiency; or receipt of immunosuppressive therapy, such as anti-cancer chemotherapy or radiation therapy; or long-term systemic corticosteroid therapy
History of microbiologically confirmed Streptococcus pneumoniae infection or disease
Any contraindication to the routine pediatric vaccine being administered in the study
History of seizure or significant stable or progressive neurologic disorders such a

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Sherwood?

Yes, this clinical trial (NCT06824194) has an active research site in Sherwood, AR that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pneumococcal infection Treatment Options in Sherwood, AR

If you're searching for pneumococcal infection treatment options in Sherwood, AR, this clinical trial (NCT06824194) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Sherwood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pneumococcal infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pneumococcal infection clinical trials near you to find additional studies recruiting in your area.

More Prurigo Nodularis Trials in Sherwood, AR

See all prurigo nodularis clinical trials recruiting in Sherwood — not just this study.

Browse Prurigo Nodularis Trials in Sherwood →

Browse More Trials by Condition

Prurigo Nodularis TrialsAll Conditions →

Ready to Join in Sherwood?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Sherwood, AR